RHEUMATIC DISEASES AND PREGNANCY (LITERATURE REVIEW)
Abstract and keywords
Abstract (English):
. The problem of pregnancy in rheumatic diseases does not lose its relevance. The most studied is the course of pregnancy in patients with rheumatoid arthritis, systemic lupus erythematosus and axial spondyloarthritis. Observations in other systemic connective tissue diseases are episodic and do not allow us to draw reliable conclusions. The course of the disease itself, as well as the therapy received by patients, can affect pregnancy, starting with the possibility of conception and ending with unfavorable pregnancy outcomes for the mother and fetus. The onset of pregnancy should be planned at the time of remission or minimal activity of the disease. Of particular interest is drug therapy in patients with rheumatic diseases during gestation. This issue has been and remains complex and has not been fully studied due to the fact that any conclusions about the effect of drugs on the fetus are made retrospectively and cannot be the result of a deliberately initiated study. Currently allowed, though with some reservations, during pregnancy drugs are glucocorticoids, non-steroidal anti-inflammatory drugs, hydroxychloroquine and sulfasalazine. The development of genetic engineering has raised the question of the possibility of using genetic engineering basic therapy during gestation. Currently, the largest number of observations is available for TNF-α inhibitors, the use of which is recognized as possible during pregnancy. The presence of rheumatic disease in itself is not an absolute indication for a caesarean section. The question of the method of delivery is decided individually. Pregnant patients with rheumatic diseases should be under regular joint supervision of an obstetrician-gynecologist, rheumatologist and neonatologist

Keywords:
pregnancy, rheumatoid arthritis, systemic lupus erythematosus, axial spondyloarthritis, antiphospholipid syndrome, sulfasalazine, hydroxychloroquine, glucocorticoids, nonsteroidal anti-inflammatory drugs, TNF-α inhibitors, delivery, lactation
References

1. Gandaloeva Z.M., Krichevskaya O.A., Gluhova S.I., Dubinina T.V., Lila A.M. Beremennost' pri ankiloziruyuschem spondilite: vzglyad pacientki i vracha // Sovremennaya revmatologiya. 2019. №13(1). S.71–79.

2. Klinicheskie rekomendacii po planirovaniyu beremennosti i nablyudeniyu za beremennymi s sistemnoy krasnoy volchankoy. https://rheumatolog.su/media/media/2018/07/18/clinrec_skv_berem.pdf

3. Krichevskaya O.A., Gandaloeva Z.M., Demina A.B., Gluhova S.I., Dubinina T.V. Bol' v spine i funkcional'nyy status u pacientok s ankiloziruyuschim spondilitom na fone beremennosti // Sovremennaya revmatologiya. 2019. №13(4). S. 26–35.

4. Krichevskaya O.A., Gandaloeva Z.M., Demina A.B., Dubinina T.V Techenie ankiloziruyuschego spondilita na fone beremennosti: promezhutochnye dannye prospektivnogo nablyudeniya // Sovremennaya revmatologiya. 2019. №13(2). S. 61–72.

5. Krichevskaya O.A., Gandaloeva Z.M., Dubinina T.V. Ankiloziruyuschiy spondilit i beremennost': sovremennyy vzglyad na problemu // Sovremennaya revmatologiya. 2018. № 3. S. 19-28.

6. Kosheleva N.M., Mat'yanova E.V.. Revmatoidnyy artrit i beremennost' // Nauchno-prakticheskaya revmatologiya. 2014. №52(6). S. 589–599.

7. Kosheleva N.M., Mat'yanova E.V., Fedorova E.V., Klimenchenko N.I. Ishody beremennosti u bol'nyh revmatoidnym artritom i sistemnoy krasnoy volchankoy. Chast' I. Materinskie ishody // Nauchno-prakticheskaya revmatologiya. 2019. №57(2). S. 180-185.

8. Mat'yanova E.V., Kosheleva N.M., Alekberova Z.S., Aleksandrova E.N. Ocenka aktivnosti revmatoidnogo artrita vo vremya beremennosti i posle rodov // Nauchno-prakticheskaya revmatologiya. 2015. № 53(2). S. 155–161.

9. Mat'yanova EV, Kosheleva NM, Alekberova ZS i dr. Vliyanie beremennosti na aktivnost' revmatoidnogo artrita i ego terapiyu po dannym prospektivnogo nablyudeniya // Nauchno-prakticheskaya revmatologiya. 2015. № 53(3). S. 266–273.

10. Mat'yanova E.V., Kosheleva N.M., Kostareva O.M. i dr. Ishody beremennosti u bol'nyh revmatoidnym artritom i sistemnoy krasnoy volchankoy. Chast' II. Neonatal'nye ishody // Nauchno-prakticheskaya revmatologiya. 2019. № 57(3). S. 289-293.

11. P.A. Shesternya, M.M. Petrova, A.O. Vasil'eva. Novye gorizonty primeneniya genno-inzhenernyh biologicheskih preparatov pri beremennosti u bol'nyh revmaticheskimi zabolevaniyami // Terapevticheskiy arhiv 2017. № 5. S. 105-112.

Login or Create
* Forgot password?